TNF and rheumatoid arthritis: Biologic disease-modifying antirheumatic drugs (bio-DMARDs), especially in the form of TNF-α inhibitors (TNFi), are established treatment options for patients with a wide variety of immunoinflammatory rheumatic diseases, including rheumatoid arthritis (RA).